Article Information
History
- July 8, 2023.
Article Versions
- You are currently viewing Version 1 of this article (July 8, 2023 - 10:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Augustine Chemparathy1,2,
- Yann Le Guen2,
- Yi Zeng3,
- John Gorzynski3,4,
- Tanner Jensen3,
- Nandita Kasireddy2,
- Lia Talozzi2,
- Michael E. Belloy2,
- Ilaria Stewart2,
- Aaron D. Gitler3,
- Anthony D. Wagner5,6,
- Elizabeth Mormino5,6,
- Victor W. Henderson2,7,
- Tony Wyss-Coray2,
- Euan Ashley3,4 and
- Michael D. Greicius2,*
- 1Stanford University School of Medicine, Stanford, CA
- 2Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA
- 3Department of Genetics, Stanford University School of Medicine, Stanford, CA
- 4Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
- 5Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA
- 6Department of Psychology, Stanford University, Stanford, CA, USA
- 7Department of Epidemiology and Population Health, Stanford University, Stanford, CA, USA
- ↵*Corresponding author:
Michael D. Greicius, Stanford Neuroscience Health Center, 290 Jane Stanford Way, Rm E261, Stanford, CA 94305-5090, greicius{at}stanford.edu, (650) 498-4624
Posted July 08, 2023.
A 3’ UTR Deletion Is a Leading Candidate Causal Variant at the TMEM106B Locus Reducing Risk for FTLD-TDP
